Dr D. Craig Brater
#150,932
Most Influential Person Now
Dr D. Craig Brater's AcademicInfluence.com Rankings
Download Badge
Chemistry
Why Is Dr D. Craig Brater Influential?
(Suggest an Edit or Addition)Dr D. Craig Brater's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pharmacist Intervention to Improve Medication Adherence in Heart Failure (2007) (487)
- BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy (2002) (384)
- Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt Diet (2000) (352)
- Improving Treatment of Late Life Depression in Primary Care: A Randomized Clinical Trial (1994) (320)
- Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. (1999) (262)
- Renal Effects of COX-2-Selective Inhibitors (2001) (249)
- Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure (1995) (246)
- Renal toxicity of the nonsteroidal anti-inflammatory drugs. (1993) (236)
- A conceptual framework to study medication adherence in older adults. (2004) (232)
- Social support and health-related quality of life in chronic heart failure patients (2004) (218)
- Furosemide absorption altered in decompensated congestive heart failure. (1985) (199)
- Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. (2001) (195)
- Diuretic therapy. (1998) (178)
- Factors Associated With Exacerbation of Heart Failure Include Treatment Adherence and Health Literacy Skills (2009) (177)
- The interaction of diltiazem with lovastatin and pravastatin (1998) (172)
- Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. (1991) (157)
- Bumetanide and furosemide in heart failure. (1984) (152)
- Loop diuretics: from the Na-K-2Cl transporter to clinical use. (2003) (149)
- Pharmacodynamic analysis of the furosemide-probenecid interaction in man. (1979) (137)
- The interaction of diltiazem with simvastatin (2000) (136)
- The time course of delivery of furosemide into urine: an independent determinant of overall response. (1982) (120)
- Furosemide in patients with heart failure: Shift in dose‐response curves (1980) (114)
- Anti-inflammatory agents and renal function. (2002) (113)
- Comparison of loop diuretics in patients with chronic renal insufficiency. (1987) (112)
- Stereoselective metabolism of ibuprofen in humans: administration of R-, S- and racemic ibuprofen. (1991) (102)
- Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. (1985) (102)
- Variable Furosemide Absorption and Poor Predictability of Response in Elderly Patients (1997) (97)
- Goth's Medical Pharmacology (1992) (94)
- Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man. (1980) (92)
- Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. (1981) (87)
- Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. (1990) (87)
- Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. (2001) (86)
- The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis (1992) (85)
- A Bayesian feedback method of aminoglycoside dosing (1985) (84)
- Absorption and disposition of furosemide in congestive heart failure. (1982) (78)
- Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension (2012) (69)
- Acute and Chronic Effects of Nonsteroidal Antiinflammatory Drugs on Glomerular Filtration Rate in Elderly Patients (1995) (69)
- Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics. (1982) (69)
- Kinetics of oral ethambutol in the normal subject (1977) (69)
- Pharmacology of diuretics. (2000) (68)
- Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. (2004) (67)
- Resistance to loop diuretics. Why it happens and what to do about it. (1985) (67)
- Pharmacodynamics of the diuretic effects of aminophylline and acetazolamide alone and combined with furosemide in normal subjects. (1983) (66)
- Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis (1993) (65)
- Effect of indomethacin on salt and water homeostasis (1979) (65)
- Nephron site of effect of nonsteroidal anti-inflammatory drugs on solute excretion in humans. (1983) (65)
- Ibuprofen-associated renal impairment in a large general internal medicine practice. (1990) (64)
- Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome. (1990) (64)
- Reliability and validity of the compliance belief scales among patients with heart failure. (2001) (64)
- Renal effects of cyclooxygyenase-2-selective inhibitors. (2002) (63)
- Clinical pharmacology in the Middle Ages: Principles that presage the 21st century (2000) (62)
- Pharmacodynamic considerations in the use of diuretics. (1983) (61)
- Update in diuretic therapy: clinical pharmacology. (2011) (60)
- Association Between Adherence to Diuretic Therapy and Health Care Utilization in Patients with Heart Failure (2003) (58)
- Bumetanide and furosemide (1983) (55)
- Controversies in COX-2 selective inhibition. (2002) (55)
- Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. (2000) (54)
- Binding inhibitors restore furosemide potency in tubule fluid containing albumin. (1991) (54)
- Response to furosemide in chronic renal insufficiency: Rationale for limited doses (1986) (54)
- Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency. (1986) (53)
- Clinical Pharmacology of NSAIDs (1988) (53)
- Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. (1994) (52)
- Drug Dosing in Patients With Impaired Renal Function (2009) (52)
- Stereoselective Pharmacokinetics and Inversion of (R)‐ Ketoprofen in Healthy Volunteers (1998) (52)
- Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status. (1989) (51)
- Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartum (1983) (50)
- The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency (1994) (48)
- Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study (2009) (48)
- Pharmacodynamics of Torsemide Administered as an Intravenous Injection and as a Continuous Infusion to Patients with Congestive Heart Failure (1996) (48)
- Depression in late life: the use of clinical characteristics to focus screening efforts. (1994) (47)
- Preliminary evaluation of furosemide-probenecid interaction in humans. (1980) (46)
- Renal effects of cyclooxygenase-2 selective inhibitors (2001) (45)
- Analysis of the effect of indomethacin on the response to furosemide in man: effect of dose of furosemide. (1979) (44)
- Medication and Dietary Compliance Beliefs in Heart Failure (2005) (43)
- Nomograms for Drug Use in Renal Disease (1981) (43)
- Lack of presystemic inversion of (R)‐ to (S)‐ibuprofen in humans (1993) (43)
- Association Between Adherence Measurements of Metoprolol and Health Care Utilization in Older Patients with Heart Failure (2005) (42)
- Defining hypercalciuria in nephrolithiasis. (2011) (40)
- Health care and medication costs and use among older adults with heart failure. (2004) (37)
- Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs. (1986) (37)
- Health literacy predicts medication adherence (2004) (36)
- Medieval Contributions to the Search for Truth in Clinical Medicine (2000) (36)
- Clinical pharmacology of loop diuretics in health and disease. (1992) (36)
- Clinical comparison of cimetidine and ranitidine (1982) (36)
- Diuretic resistance: mechanisms and therapeutic strategies. (1994) (36)
- The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency (1994) (35)
- Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial. (1990) (35)
- Ethambutol kinetics in patients with impaired renal function. (1986) (33)
- Azosemide, a “loop” diuretic, and furosemide (1979) (33)
- Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination. (1999) (33)
- Disposition kinetics of ethambutol in man (1980) (32)
- Benefits and Risks of Torasemide in Congestive Heart Failure and Essential Hypertension (1996) (32)
- Clinical Pharmacology of Loop Diuretics (2012) (32)
- Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin. (1986) (32)
- Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure. (1996) (31)
- Disposition and response to bumetanide and furosemide. (1986) (31)
- Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide (2000) (31)
- Resistance to Loop Diuretics (1985) (30)
- Effects of NSAIDs on the kidney. (1997) (30)
- Systemic drug interactions with topical glaucoma medications. (1990) (30)
- A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers. (2009) (30)
- Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics. (1986) (29)
- Stereoselective disposition of flurbiprofen in normal volunteers. (1992) (29)
- Medical student education in clinical pharmacology and therapeutics. (1988) (29)
- Measurement of renal function during drug development. (2002) (28)
- Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study. (2004) (28)
- Nonsteroidal anti-inflammatory drugs. (1990) (28)
- Gas-liquid chromatographic determination of pseudoephedrine and norpseudoephedrine in human plasma and urine. (1977) (28)
- Exaggerated natriuretic and calciuric responses to hydrochlorothiazide in renal hypercalciuria but not in absorptive hypercalciuria. (1985) (28)
- Diuretic Pharmacokinetics and Pharmacodynamics (1997) (27)
- Viewpoint: infusing professionalism into a school of medicine: perspectives from the dean. (2007) (27)
- Pharmacokinetics of Didanosine and Ketoconazole After Coadministration to Patients Seropositive for the Human Immunodeficiency Virus (1993) (27)
- Effects of flurbiprofen on renal function in patients with moderate renal insufficiency. (1992) (26)
- Mechanisms of the synergistic combination of metolazone and bumetanide. (1985) (26)
- Clinical aspects of renal prostaglandins and NSAID therapy. (1988) (26)
- Pharmacokinetics of loop diuretics in congestive heart failure. (1994) (26)
- Drug use in renal disease (1983) (25)
- Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs. (2012) (25)
- Resistance to diuretics: emphasis on a pharmacological perspective. (1981) (24)
- Clinical Pharmacology of Cefotaxime in Pediatric Patients (1981) (23)
- Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man. (1980) (23)
- Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment. (1995) (22)
- Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis. (1992) (22)
- Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action (2017) (22)
- The effect of nonsteroidal antiinflammatory drugs on electrolyte homeostasis and blood pressure in young and elderly persons with and without renal insufficiency. (1997) (21)
- Renal sites of action of azosemide (1979) (21)
- Increase in diuretic effect of chlorothiazide by probenecid (1978) (21)
- Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside. (1983) (21)
- Risk of hyperkalemia associated with selective COX‐2 inhibitors (2010) (20)
- Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy (2004) (19)
- Diuretic therapy in congestive heart failure. (2000) (19)
- Bayesian and Least‐Squares Methods for Vancomycin Dosing (1987) (19)
- Recommendations of the National Football League Physician Society Task Force on the Use of Toradol® Ketorolac in the National Football League (2012) (18)
- Digoxin toxicity in patients with normokalemic potassium depletion (1977) (18)
- Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats. (1992) (18)
- Aminoglycoside dosing in pediatric patients. (1989) (17)
- Profile of etodolac: Pharmacokinetic evaluation in special populations (1989) (17)
- Dependence of urinary prostaglandin E2 excretion on urinary volume rather than solute handling or segmental nephron function in man. (1984) (16)
- Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program (2009) (16)
- Stereoselective disposition of flurbiprofen in uraemic patients. (1992) (16)
- Electrolyte Excretion Patterns. Intravenous and Oral Doses of Bumetanide Compared to Furosemide (1981) (15)
- Cardiovascular drug interactions. (1977) (15)
- Aminoglycoside dosage adjustment in renal failure: A hand-held calculator program (2004) (14)
- Attenuation of furosemide's diuretic effect by indomethacin: Pharmacokinetic evaluation (1979) (14)
- Pharmacogenetics and healthcare outcomes in patients with chronic heart failure (2012) (14)
- In vitro evidence that urine composition affects the fraction of active furosemide in the nephrotic syndrome. (1989) (14)
- Misuse of cimetidine. (1980) (14)
- A comparison of azosemide, a new loop diuretic, to furosemide (1979) (14)
- Intravenous diltiazem and CYP3A-mediated metabolism. (2000) (14)
- Systemic alkalosis and digitalis related arrhythmias. (2009) (13)
- Clearance of furosemide by the gastrointestinal tract. (1986) (13)
- Highly sensitive measurement of indomethacin using a high-performance liquid chromatographic technique combined with post-column in-line hydrolysis. (1986) (13)
- Furosemide pharmacokinetics and pharmacodynamics in renal transplantation (1988) (13)
- Statement on the release of ibuprofen as an over-the-counter medicine. Ad Hoc Committee for the National Kidney Foundation. (1985) (13)
- Rational therapeutics : a clinical pharmacologic guide for the health professional (1990) (13)
- Pharmacokinetics and pharmacodynamics of torasemide in health and disease. (1993) (12)
- The pharmacokinetics of piroxicam in elderly persons with and without renal impairment. (1994) (11)
- Differences in Response of Black Hypertensives to Alpha vs. Beta Adrenergic Antagonists: Preliminary Findings (1985) (10)
- Pocket manual of drug use in clinical medicine (1989) (10)
- Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques (1997) (10)
- Loop diuretics : translating pharmacokinetic properties into improved clinical outcomes (2001) (9)
- Indomethacin secretion in the isolated perfused proximal straight rabbit tubule. Evidence for two parallel transport mechanisms. (1988) (8)
- Prolonged hemodynamic effect of furosemide in congestive heart failure. (1984) (8)
- Determinants of the overall response to furosemide: pharmacokinetics and pharmacodynamics. (1983) (8)
- Renal hemodynamic effects of therapeutic plasma levels of sulindac sulfide during hemorrhage. (1986) (8)
- Clinical pharmacology: Where has the support gone? (1990) (7)
- Lack of effect of prostaglandin inhibition on calcium excretion in normal volunteers. (1985) (7)
- Materno-fetal transfer of azlocillin. (1983) (7)
- Variability in derived parameters of furosemide pharmacokinetics (1981) (7)
- Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives. (1984) (7)
- Effect of doxepin on basal gastric acid and salivary secretion in patients with duodenal ulcer. (1986) (7)
- The generic prescribing issue. (1980) (6)
- A Model for Engaging Public–Private Partnerships (2011) (6)
- Use of drugs in patients with renal insufficiency. Workshop report. (1994) (6)
- Penicillin G Therapy in Renal Failure (1975) (6)
- Resistance to Diuretics (1981) (5)
- A Pharmacokinetic and Endoscopic Comparison of an Oral and an Experimental Buccal Piroxicam Formulation (1992) (5)
- High-pressure liquid chromatographic assay and pharmacokinetics of HR 810 after intramuscular injection in rabbits (1985) (5)
- Eicosanoids and hypertension. (1990) (5)
- CHAPTER 98 – Disposition and Dose Requirements of Drugs in Renal Insufficiency (2008) (5)
- Use of diuretics in cirrhosis and nephrotic syndrome. (1999) (5)
- Cyclooxygenase-2 Inhibition and Renal Function (2001) (4)
- Clinical pharmacology of etintidine in patients with duodenal ulcer (2004) (4)
- Renal Effects of Ibuprofen (1999) (4)
- Resistance to diuretics: mechanisms and clinical implications. (1993) (3)
- Chapter 91 – Drug Dosing in Renal Failure (2008) (3)
- Micro-HPLC and transfer techniques for directly measuring drug (indomethacin) transport across the isolated perfused renal proximal straight tubule. (1988) (3)
- Quantitative Recovery of Uranium Hexafluoride from a Process Gas Stream (1959) (3)
- Bayesian dosing of anesthetic agents: esoteric or practical? (1988) (3)
- Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites. (2001) (3)
- Evaluation of etodolac in subjects with renal impairment. (1990) (3)
- Effects of atenolol, nadolol and propranolol on renal haemodynamics (1983) (3)
- Pharmacokinetics of torsemide in chronic renal insufficiency (1991) (2)
- Academic internal medicine: challenges and opportunities-part II. (2000) (2)
- THE DEVELOPMENT OF A HIGH CAPACITY, CONTINUOUS PROCESS FOR THE PREPARATION OF URANIUM HEXAFLUORIDE FROM URANIUM OXIDES AND ORE CONCENTRATES (1958) (2)
- Development of the Continuous Method for the Reduction of Uranium Hexafluoride With Hydrogen-Process Development. Hot Wall Reactor (1958) (2)
- Metolazone pharmacokinetics and pharmacodynamics in renal transplantation. (1991) (2)
- Diuretic resistance: why it happens and what to do about it (1985) (2)
- The use of diuretics in congestive heart failure. (1994) (2)
- Cyclooxygenase-2 inhibition and renal function (multiple letters) (2001) (2)
- Use of diuretics in chronic renal insufficiency and nephrotic syndrome. (1988) (2)
- The Pharmacological Role of the Kidney (2012) (2)
- RECOVERY OF URANIUM HEXAFLUORIDE FROM A PROCESS GAS STREAM BY ABSORPTION- DISTILLATION TECHNIQUES EMPLOYING A LIQUID FLUORO-CARBON MEDIUM (1959) (1)
- VAPO-METALLURGY. ARTICLE III. PREPARATION OF REFRACTORY METAL POWDERS WITH UNUSUAL PROPERTIES (1965) (1)
- Panel I. Drug utilization review: Criteria * (1991) (1)
- Renal Safety of Ibuprofen: Pharmacokinetic Aspects (1998) (1)
- 6 – The Impact of Renal Dysfunction on Drug Handling and How to Compensate for It (1990) (1)
- CONTINUOUS PROCESSES FOR THE DIRECT REDUCTION OF URANIUM HEXAFLUORIDE TO URANIUM TETRAFLUORIDE OF HIGH PURITY AND DENSITY (1958) (1)
- Olanzapine and warfarin drug interaction (1997) (1)
- Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency—Preliminary evaluation (2004) (1)
- ASSIST: A Clinically Oriented Drug Level Forecasting System. (1985) (1)
- Editorials: Rational drug therapy in patients with renal disease. (1975) (0)
- Ask drug therapy®. A question-and-answer seminar from the drug therapy experts (1994) (0)
- ORGDP FUEL REPROCESSING STUDIES SUMMARY PROGRESS REPORT, JULY THROUGH DECEMBER, 1965 (1966) (0)
- CONTINUOUS PROCESS FOR THE CONVERSION OF UF$sub 6$ TO UF$sub 4$ (1959) (0)
- Renal Disposition of Drugs and Translation to Dosing Strategies (2013) (0)
- RECOVERY OF URANIUM HEXAFLUORIDE FROM FEED PLANT VENT GASES (1959) (0)
- Letter to the Editor Response (2013) (0)
- A Message from the President—Come to San Francisco, March 21–23, 1990 (1990) (0)
- Pharmacogenetics and healthcare outcomes in patients with chronic heart failure (2012) (0)
- Diuretics in congestive heart failure which one, what dose, and does it make a difference? (2000) (0)
- Guidelines for Development of a New Diuretic Agent (1993) (0)
- Use of Drugs in Uremia and Dialysis (1991) (0)
- ANY QUESTIONS (1995) (0)
- Renal effects of cyclooxygyenase-2-selective inhibitors. Commentary (2002) (0)
- Proceedings from the Symposium "The Evolution of Anti-Inflammatory Treatments in Arthritis: Current and Future Perspectives" (2002) (0)
- Fuel Cycle Costs for a Plutonium Recycle System (1964) (0)
- Serum electrolyte abnormalities caused by drugs. (1986) (0)
- Future of the American Society for Clinical Pharmacology and Therapeutics. (1990) (0)
- Back to basics: lidocaine (1984) (0)
- Goths medical pharmacology (2013) (0)
- Amino acid sequence analysis of human ribosomal proteins. ORNL-4419. (1969) (0)
- Abstract 853: Short-Term Elevations in Blood Pressure Levels in Arthritis Patients Receiving Diclofenac or Etoricoxib in the MEDAL Program was not Associated with Subsequent Increased Risk of Thrombotic Cardiovascular Events (2008) (0)
- Update of cardiovascular drug interactions. (1985) (0)
- Forum—Letter to the editorReply (1985) (0)
- Effect of albumin infusion on response to furosemide in patients with cirrhotic ascites (2000) (0)
- Author index (2008) (0)
- Letter: Penicillin G therapy in renal failure. (1975) (0)
- Ninetieth Anniversary Celebration (1989) (0)
- Oral but not intravenous (IV) diltiazem impairs lovastatin clearance (1999) (0)
- FLUID-BED VOLATILITY COMPONENT, ENGINEERING FEASIBILITY, AND SCALE-UP STUDIES AT THE OAK RIDGE GASEOUS DIFFUSION PLANT. (1966) (0)
- Commentary 1 (2012) (0)
- Development and production experience with mechanically agitated fluid beds as applied to the hydrofluorination of fine uranium oxide powders (1964) (0)
- Therapeutic options in CHF - focus on diuretics : proceedings from the Heart Failure Update symposium held in Venice, Italy 28 June - 1 July 2000 (2001) (0)
- A Message from the President—Come to San Francisco, March 21–23, 1990 (1989) (0)
- CAPITAL AND OPERATING COST ESTIMATES FOR CONVERSION OF URANIUM HEXAFLUORIDE TO URANO-URANIC OXIDE AT RATES OF 1, 10, AND 30 TONS OF URANIUM PER DAY (1963) (0)
- The Influence of Misoprostol on the Adverse Renal Effects and Stereospecific Pharmacokinetics of Ibuprofen in Chronic Renal Insufficiency. (1995) (0)
- The American Society for Clinical Pharmacology and Therapeutics: programs to support education in clinical pharmacology. (1990) (0)
- Clinical importance of cardiovascular drug interactions. (1981) (0)
- Effect of sulfisoxazole on the pharmaco‐dynamics of furosemide in patients with nephrotic syndrome (1999) (0)
- Congratulations to investigators (2000) (0)
- ORGDP FUEL REPROCESSING STUDIES SUMMARY PROGRESS REPORT, FISCAL YEAR 1964 THROUGH FISCAL YEAR 1965 (1965) (0)
- 2017 Reviewer Acknowledgment (2018) (0)
- Pharmacology and efficacy of cyclooxygenase (COX) inhibitors. Discussion (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dr D. Craig Brater?
Dr D. Craig Brater is affiliated with the following schools:
